Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-13 5:02 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | VANGUARD GROUP INC | 10,834,483 7.84% | 887,385 (+8.92%) | View |
| 2024-02-13 4:27 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | BRATTON DOUGLAS K | 5,750,882 4.2% | -1,250,000 (-17.85%) | View |
| 2024-02-12 7:07 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | BIOGEN INC. BIIB | 12,751,365 9.23% | -558,878 (-4.20%) | View |
| 2024-02-08 10:11 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | WELLINGTON MANAGEMENT GROUP LLP | 7,274,717 5.26% | 7,274,717 (New Position) | View |
| 2024-01-30 06:59 am Sale | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 14,260,724 10.32% | -858,750 (-5.68%) | View |
| 2024-01-30 06:40 am Unchanged | 13G | DENALI THERAPEUTICS INC DNLI | Temasek Holdings (Private) Ltd | 6,895,992 4.9% | 0 (Unchanged) | View |
| 2024-01-25 4:59 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 11,542,861 8.4% | 2,221,432 (+23.83%) | View |
| 2023-03-30 06:14 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | Temasek Holdings (Private) Ltd | 6,895,992 5% | 6,895,992 (New Position) | View |
| 2023-02-13 4:14 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | BRATTON DOUGLAS K | 7,000,882 5.2% | -844,307 (-10.76%) | View |
| 2023-02-09 11:16 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | VANGUARD GROUP INC | 9,947,098 7.32% | 1,785,568 (+21.88%) | View |
| 2023-02-09 08:14 am Sale | 13G | DENALI THERAPEUTICS INC DNLI | FMR LLC | 5,854,035 4.31% | -737,998 (-11.20%) | View |
| 2023-01-31 5:52 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 9,321,429 6.9% | 1,210,607 (+14.93%) | View |
| 2023-01-20 10:05 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 15,119,474 11.13% | 63,093 (+0.42%) | View |
| 2022-02-14 2:37 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | BRATTON DOUGLAS K | 7,845,189 6.4% | -4,503,595 (-36.47%) | View |
| 2022-02-14 2:34 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | PRICE T ROWE ASSOCIATES INC | 4,635,433 3.7% | -1,829,393 (-28.30%) | View |
| 2022-02-09 3:43 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | VANGUARD GROUP INC | 8,161,530 6.68% | 236,473 (+2.98%) | View |
| 2022-02-09 09:11 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | FMR LLC | 6,592,033 5.397% | 424,096 (+6.88%) | View |
| 2022-02-08 3:04 pm Sale | 13G | DENALI THERAPEUTICS INC DNLI | ARCH Venture Fund VIII L.P. | 0 0% | -10,735,948 (Position Closed) | View |
| 2022-02-03 4:41 pm Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BlackRock Inc. BLK | 8,110,822 6.6% | 1,734,744 (+27.21%) | View |
| 2022-01-18 11:50 am Purchase | 13G | DENALI THERAPEUTICS INC DNLI | BAILLIE GIFFORD & CO | 15,056,381 12.33% | 2,866,125 (+23.51%) | View |